Cargando…

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their families. Patients with cancer, particularly those with haematologic malignancies, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giesen, Nicola, Sprute, Rosanne, Rüthrich, Maria, Khodamoradi, Yascha, Mellinghoff, Sibylle C., Beutel, Gernot, Lueck, Catherina, Koldehoff, Michael, Hentrich, Marcus, Sandherr, Michael, von Bergwelt-Baildon, Michael, Wolf, Hans-Heinrich, Hirsch, Hans H., Wörmann, Bernhard, Cornely, Oliver A., Köhler, Philipp, Schalk, Enrico, von Lilienfeld-Toal, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874914/ https://www.ncbi.nlm.nih.gov/pubmed/33676266 http://dx.doi.org/10.1016/j.ejca.2021.01.033

Ejemplares similares

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Giesen, Nicola, et al.
Publicado: (2020)

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
por: Giesen, Nicola, et al.
Publicado: (2023)

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus
por: Henze, Larissa, et al.
Publicado: (2022)

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
por: Kochanek, Matthias, et al.
Publicado: (2019)

Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
por: Sandherr, Michael, et al.
Publicado: (2015)

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Stemler, Jannik, et al.
Publicado: (2023)

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
por: Rieger, C T, et al.
Publicado: (2018)

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
por: Penack, Olaf, et al.
Publicado: (2014)

Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
por: Rüthrich, Maria Madeleine, et al.
Publicado: (2022)

Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Mellinghoff, Sibylle C., et al.
Publicado: (2017)

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
por: Classen, Annika Y., et al.
Publicado: (2021)

Impfung gegen SARS-CoV-2 bei Krebspatienten
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2021)

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Heinz, W. J., et al.
Publicado: (2017)

Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Böll, Boris, et al.
Publicado: (2020)

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Christopeit, Maximilian, et al.
Publicado: (2020)

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
por: Neumann, S., et al.
Publicado: (2013)

Infektionsmanagement in der Hämatologie und Onkologie: Verantwortungsvoller Einsatz von Antiinfektiva
por: Classen, Annika Yanina, et al.
Publicado: (2022)

Influenza virus infections in patients with malignancies –– characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO)
por: Hermann, B., et al.
Publicado: (2016)

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Schmidt-Hieber, M., et al.
Publicado: (2017)

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2020)

Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching
por: Grothe, Jan, et al.
Publicado: (2022)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
por: Sprute, Rosanne, et al.
Publicado: (2021)

Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2016)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
por: Sprute, Rosanne, et al.
Publicado: (2022)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

CCC meets ICU: Redefining the role of critical care of cancer patients
por: von Bergwelt-Baildon, Michael, et al.
Publicado: (2010)

Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
por: Sprute, Rosanne, et al.
Publicado: (2021)

EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections
por: Sprute, Rosanne, et al.
Publicado: (2022)

The silent flucytosine shortage in Europe – not a distant problem
por: Sprute, Rosanne, et al.
Publicado: (2023)

Teaching an old dog new tricks: next-generation CAR T cells
por: Tokarew, Nicholas, et al.
Publicado: (2018)

Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
por: Mousset, Sabine, et al.
Publicado: (2013)

Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle
por: Wehrmann, Florian, et al.
Publicado: (2023)

Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once
por: Cordas dos Santos, David Manuel, et al.
Publicado: (2021)

Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018)

Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature
por: Feldmann, Georg, et al.
Publicado: (2013)

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study
por: Wimmer, Thomas, et al.
Publicado: (2022)

Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
por: Pinto, Catarina, et al.
Publicado: (2020)

Pneumonien bei immunsupprimierten Patienten
por: Moeser, A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7pbjc13ot2srti3c23ni5umv1a